Lucentra consumer app · Pessimistic · Probable · Optimistic
| Tier | Monthly | Annual | Daily AI msgs | Mix assumption |
|---|---|---|---|---|
| Free (7-day trial) | £0 | — | 10 | — |
| Standard | £19.99 | £239.88 | 100 | 35% |
| Pro | £29.99 | £359.88 | 150 | 50% |
| Pro+ (most features) | £44.99 | £449 (save £90) | 200 | 15% |
Blended monthly ARPU: 0.35 × £19.99 + 0.50 × £29.99 + 0.15 × £44.99 = £28.74 / month. Blended annual revenue per paid user (after Apple IAP commission and Stripe processing fees, rounded down for prudence): ~£336 / year.
Free → paid conversion rate: 3% honest-floor planning baseline (consumer wellness apps benchmark 2-5%; the conservative end of that range is what's used in the Pessimistic and Probable scenarios below).
Cost discipline: cost per AI message £0.00634 with cached Claude Sonnet; blended gross margin 63.8% at 30% usage; all four paid tiers loss-proof at worst-case 100% daily usage. Add-on credit packs at 65% margin. Unit economics positive from user one.
| Metric | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | 5-yr total |
|---|---|---|---|---|---|---|
| End-of-year paid users | 850 | 2,030 | 4,400 | 7,500 | 10,500 | — |
| Avg paid users (triangle approx) | 425 | 1,440 | 3,215 | 5,950 | 9,000 | — |
| Annual revenue (avg × £336) | £142,800 | £483,840 | £1,080,240 | £1,999,200 | £3,024,000 | £6,730,080 |
| End-of-year ARR (snapshot) | £285,600 | £682,080 | £1,478,400 | £2,520,000 | £3,528,000 | — |
Reality check: at this trajectory cumulative gross revenue across the 5 years is approximately £6.73M. The Pessimistic case is the worst plausible outcome and is shown for honesty, not as a target. Even in this scenario the business is profitably operating at end of year 5 (gross margin 63.8% at sustained usage = ~£2.2M cumulative gross profit).
| Metric | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | 5-yr total |
|---|---|---|---|---|---|---|
| End-of-year paid users | 2,700 | 10,140 | 24,500 | 44,000 | 66,000 | — |
| Avg paid users (triangle approx) | 1,350 | 6,420 | 17,320 | 34,250 | 55,000 | — |
| Annual revenue (avg × £336) | £453,600 | £2,157,120 | £5,819,520 | £11,508,000 | £18,480,000 | £38,418,240 |
| End-of-year ARR (snapshot) | £907,200 | £3,407,040 | £8,232,000 | £14,784,000 | £22,176,000 | — |
Base-case logic: the consumer-wellness ARR / user-count progression is well-bounded by SaaS benchmarks for category leaders (Calm, Headspace) at equivalent stages. A UK-incorporated longevity app with a 3-patent IP portfolio (Bodhi filed 2026-04-08; Lucentra app GB2611164.1 filed 2026-05-13; BMS GB2608130.7 filed 2026-05-13 — all UK provisional in joint Clive + Jenny Olsson-Chattey names), full agency-quality marketing, and a 3-companion architecture should comfortably exceed 1% of category-leader benchmarks within 5 years.
| Metric | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | 5-yr total |
|---|---|---|---|---|---|---|
| End-of-year paid users | 6,750 | 27,000 | 76,000 | 130,000 | 180,000 | — |
| Avg paid users (triangle approx) | 3,375 | 16,875 | 51,500 | 103,000 | 155,000 | — |
| Annual revenue (avg × £336) | £1,134,000 | £5,670,000 | £17,304,000 | £34,608,000 | £52,080,000 | £110,796,000 |
| End-of-year ARR (snapshot) | £2,268,000 | £9,072,000 | £25,536,000 | £43,680,000 | £60,480,000 | — |
Why this is the upper bound, not a target: the Optimistic case requires PR breakthrough, conversion uplift, and churn improvement to compound simultaneously. Each individual lever is plausible — each has been hit by a category leader. Compounding all four together is statistically less probable than the base case.
| Metric | Pessimistic | Probable | Optimistic |
|---|---|---|---|
| End-of-Y5 paid users | 10,500 | 66,000 | 180,000 |
| End-of-Y5 ARR | £3.53M | £22.18M | £60.48M |
| 5-yr cumulative revenue | £6.73M | £38.4M | £110.8M |
| Free → paid conversion | 1.5% | 3% | 5% |
| Annual gross churn | 40% | 25% | 15% |
Every forecast is a model, not a prediction. These three scenarios bracket what's plausible given the existing product state and the launch levers under Lucentra's control. The Probable case assumes a delivery partner of senior-craft quality executing the agreed scope; without that, the trajectory bends toward Pessimistic. The Optimistic case requires conditions outside any single party's control (PR breakthrough, influencer pickup, network-effect compounding) — useful as an upper bound, not a plan.
Every number above is bottom-up from internal commercial analysis. None has been imported from external decks or marketing material. Comparable benchmarks (Calm, Headspace, similar consumer-wellness category leaders) are referenced as sanity checks not as targets.